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Net1 is a RhoA-specific guanine nucleotide exchange factor which localizes to the nucleus at steady state. A
deletion in its N terminus redistributes the protein to the cytosol, where it activates RhoA and can promote
transformation. Net1 contains a PDZ-binding motif at the C terminus which is essential for its transformation
properties. Here, we found that Net1 interacts through its PDZ-binding motif with tumor suppressor proteins
of the Dlg family, including Dlg1/SAP97, SAP102, and PSD95. The interaction between Net1 and its PDZ
partners promotes the translocation of the PDZ proteins to nuclear subdomains associated with PML bodies.
Interestingly, the oncogenic mutant of Net1 is unable to shuttle the PDZ proteins to the nucleus, although these
proteins still associate as clusters in the cytosol. Our results suggest that the ability of oncogenic Net1 to
transform cells may be in part related to its ability to sequester tumor suppressor proteins like Dlg1 in the
cytosol, thereby interfering with their normal cellular function. In agreement with this, the transformation
potential of oncogenic Net1 is reduced when it is coexpressed with Dlg1 or SAP102. Together, our results
suggest that the interaction between Net1 and Dlg1 may contribute to the mechanism of Net1-mediated
transformation.
The Rho family of small GTPases represents a major branch
of the Ras superfamily and consists of 22 distinct genes, with
RhoA, Rac1, and Cdc42 being the most intensely studied and
best characterized family members (67). Rho GTPases control
many aspects of cell behavior, such as the organization of the
cytoskeleton, cell migration, cell-cell and cell-matrix adhesion,
cell cycle progression, gene expression, and cell polarity (7,
24, 65).
Like all GTPases, Rho proteins act as molecular switches by
cycling between an active (GTP-bound) and an inactive (GDP-
bound) state. Active GTPases interact with high affinity with
one of several downstream effectors to modulate their activity
and localization. The activation of Rho GTPases is regulated
by specific guanine nucleotide exchange factors (GEFs), which
catalyze the exchange of GDP for GTP. Signaling is terminated
when GTP is hydrolyzed to GDP, a process stimulated by
GTPase-activating proteins. In addition, a third family of pro-
teins, the guanine nucleotide dissociation inhibitors, negatively
regulate Rho GTPases by sequestering them in the cytoplasm
and interfering with both the GDP/GTP exchange and the
GTP hydrolysis (65).
More than 70 Rho GEFs and 70 Rho GTPase-activating
proteins are encoded by the human genome, allowing for path-
way-specific regulation of Rho protein activity (51, 62). In
addition, Rho GTPases interact with a wide variety of effectors
and act as key players at the crossroads of signal integration
and transduction (7, 24, 65).
Rho GEFs comprise a highly diverse family of proteins that
share a common catalytic domain (Dbl homology [DH]), fol-
lowed by a Pleckstrin homology (PH) domain, but are very
different otherwise in their domain structures (51, 54). A strik-
ing feature of Rho GEFs is that they outnumber their target
GTPases by a factor of 3, which means that multiple GEFs are
capable of activating the same GTPase. In addition, many
GEFs can activate more than one GTPase (51, 54). One of the
fundamental questions in the field is how a cell utilizes specific
combinations of GEF, GTPase, and effector to elicit defined
responses to specific extracellular stimuli.
We have recently shown that 26 out of 70 Rho GEFs of the
human DH family (37%) contain a putative PDZ-binding mo-
tif at the C terminus (18). These binding motifs are present in
almost all of the corresponding mouse homologs, suggesting an
evolutionarily conserved role. PDZ domains are protein-pro-
tein interaction domains that act as scaffolds to concentrate
signaling molecules at specialized regions in the cell. In recent
years, a series of PDZ proteins have been found to interact
with Rho GEFs (18). These interactions result in targeting of
the Rho GEFs to specific locations within the cell, in the
restriction of the nucleotide exchange activity of Rho GEFs
and also affect the spatial and temporal activation of the down-
stream GTPases (5, 11, 12, 37, 46, 47, 50).
Neuroepithelioma transforming gene 1 (Net1) is a RhoA-
specific GEF that was originally identified in a genetic screen
* Corresponding author. Mailing address: Department of Cell and
Developmental Biology, University of North Carolina at Chapel Hill,
12-026 Lineberger, CB#7295, Chapel Hill, NC 27599. Phone: (919)
966-5783. Fax: (919) 966-3015. E-mail: rafaelgm@med.unc.edu.
† Supplemental material for this article may be found at http://mcb
.asm.org/.
 Published ahead of print on 15 October 2007.
8683
for novel oncogenes (8). The NET1 gene encodes a 595-amino-
acid protein that consists of an N-terminal domain containing
a series of nuclear localization signals (NLS), a DH-PH do-
main, and a short C-terminal domain carrying a consensus
PDZ-binding motif (Fig. 1A). At steady state, Net1 localizes to
the nucleus through the function of its NLS (55). Deletion of
the N-terminal domain containing the NLS sequences redis-
tributes Net1 to the cytosol and promotes the formation of
actin stress fibers, which is a consequence of RhoA activation
(2, 55). The oncogenic Net1 clone isolated in the original
screen encoded a truncated protein in which the first 145
amino acids, including the NLS, were missing, suggesting that
relocalization of the RhoA exchange activity to the cytosol was
responsible for the transformation ability of Net1 (8, 55). How-
ever, further studies demonstrated that a high exchange activ-
ity in the cytosol was not sufficient to induce transformation
(49). In addition, these studies demonstrated that the PDZ-
binding motif was essential for Net1-mediated transformation
of NIH 3T3 cells, suggesting that the interaction between Net1
and a PDZ domain protein could be playing a role.
In this study, we show that PDZ domain-containing proteins
of the membrane-associated guanylate kinase (MAGUK) fam-
FIG. 1. Mouse brain, kidney, or liver lysates were incubated with streptavidin-Sepharose beads coupled with biotinylated peptides correspond-
ing to the last 10 amino acids of Net1 or control (ctrl) peptides in which the last 4 amino acids were replaced by glycine (underlined). After being
washed, the samples were separated by SDS-PAGE and the indicated bands were identified by MS as described in Materials and Methods.
(A) Domain structure of the Net1 protein. (B) Peptide sequences used in this study. The peptides were biotinylated and contained an N-terminal
glycine residue as a spacer. (C) SDS-PAGE gels from two representative experiments showing the proteins identified. Gels were stained with
Coomassie blue. The bands of interest were cut from the gel and identified at the MS facility at UNC. Molecular mass markers (kDa) are indicated
in each panel. (D) Protein identities were confirmed by Western blot analysis using commercially available antibodies. Peptide pulldowns were
performed as described for panel C. Proteins were separated by SDS-PAGE and immunoblotted for PSD95, Dlg1, SAP102, and Lin7C.
(E) Pulldown assay using brain lysates (PSD95, SAP102, and Lin7) or liver lysates (Dlg1) and GST-Net1 or a deletion mutant missing the
PDZ-binding motif (GST-Net14). The precipitated proteins were immunoblotted with anti-PSD95, anti-Dlg1, and anti-SAP102 antibodies. The
same blot was subsequently stripped and immunoblotted using anti-Net1 antibodies to verify the levels of GST-Net1 constructs in the assay.
(F) Pulldown assay using brain lysates (PSD95) or liver lysates (Dlg1) and GST-Net1; a deletion mutant missing the PDZ-binding motif
(GST-Net14) or a single-amino-acid-substitution mutant in the PDZ-binding motif (GST-Net1V3A). The precipitated proteins were immuno-
blotted with anti-PSD95 and anti-Dlg1 antibodies. The same blot was subsequently stripped and immunoblotted using anti-Net1 antibodies to
verify the levels of GST-Net1 constructs in the assay. (G) Coprecipitation of endogenous Dlg1 and Net1 from HEK293 lysates. HEK293 lysates
were incubated with anti-Dlg1 or with control antibodies, and the precipitates (IP) were immunoblotted for Net1. Net1 coprecipitated only with
Dlg1, not with control antibodies.
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ily, including the tumor suppressor Dlg1/SAP97, bind to Net1.
Their interaction results in the translocation of its PDZ part-
ners to subnuclear structures associated with promyelocytic
leukemia protein (PML) bodies. In contrast, the oncogenic
mutant of Net1 which lacks the NLS binds to and sequesters
these same PDZ proteins in the cytosol. Our results suggest
that the interaction between Net1 and tumor suppressor pro-
teins such as Dlg1 or SAP102 may contribute to the mechanism
of Net1-mediated transformation.
MATERIALS AND METHODS
Antibodies and cDNA constructs. The following antibodies were used: anti-
PSD95 (Upstate); anti-SAP97/Dlg1 (StressGen); anti-Dlg1, anti-RhoA, and anti-
phosphotyrosine (PY99) (Santa Cruz); antiphosphothreonine and antiphospho-
serine (Zymed); anti-SAP102, polyclonal anti-myc, and anti-Net1 (AbCam);
anti-Lin7, antitubulin, antivinculin, and anti-FLAG (M2) (Sigma); anti-
LaminA/C (BD Biosciences); antiactin (clone 1501) (Calbiochem); monoclonal
anti-myc (Invitrogen); and anti-green fluorescent protein (anti-GFP) (Roche).
Antibodies against SC35, PML, and coilin were a kind gift from Karl Fu (Uni-
versity of Alabama at Birmingham). For Western blotting, the primary antibod-
ies were detected using horseradish peroxidase-conjugated secondary antibodies
(Jackson Inmmunoresearch) with SuperSignal West Pico detection reagents
(Pierce). Alexa 594-, 488-, and 350-conjugated anti-mouse and anti-rabbit sec-
ondary antibodies were from Molecular Probes. Alexa 594-phalloidin was from
Molecular Probes. Rat PSD95 fused to GFP and rat SAP102 in pCDNA3 were
generous gifts from Mike Ehlers (Duke University). SAP102 was subcloned into
pEGFP-C2 (Clontech). Mouse Dlg1 was purchased from Open Biosystems (no.
9200268) and subcloned into pEGFP-C2. Net1 and Net1A cDNAs were pur-
chased from Origene and subcloned into pCMVmyc (Clontech). mCherry was a
kind gift from Klaus Hahn (University of North Carolina [UNC]). Deletion
mutants were made using conventional PCR cloning techniques. 4 mutations
(Net4 and Net4) were made by introducing a stop codon before the
PDZ-binding motif, using a QuikChange II mutagenesis kit (Stratagene). V3A
and L267 substitutions were also made using a QuikChange II mutagenesis kit.
All constructs were verified by DNA sequencing.
Cell culture and transfection. HeLa cells were cultured in modified Eagle’s
medium (Invitrogen) supplemented with nonessential amino acids, 10% fetal
bovine serum (FBS) (Sigma), and antibiotics (penicillin-streptomycin). HEK293
cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Invitro-
gen) supplemented with nonessential amino acids, 10% FBS, and antibiotics.
NIH 3T3 cells were cultured in DMEM supplemented with 10% bovine calf
serum and antibiotics (Sigma). MCF10a cells were cultured in DMEM-F12
(Invitrogen) supplemented with 5% horse serum (Invitrogen), 20 ng/ml epider-
mal growth factor (Sigma), 0.01 mg/ml insulin (Invitrogen), 500 ng/ml hydro-
cortisone (Invitrogen), and antibiotics. MCF7 cells were grown in minimal es-
sential medium (Invitrogen) supplemented with FBS, Na pyruvate (Invitrogen),
and antibiotics. Cells were transfected using FuGene6 or FuGene HD (Roche)
according to the manufacturer’s instructions.
Small interfering RNA (siRNA) against human Net1 was from Dharmacon
Research. The RNA sequences were as follows: sense, 5-GAGUCUCCCUUC
AGUCGAAUU-3, and antisense, 5-UUCGACUGAAGGGAGACUCUU-3.
As a control, we used siGLO RISC-Free nontargeting siRNA (Dharmacon).
HEK293 cells were transfected using the TransIT siQuest transfection reagent
(Mirus), following the manufacturer’s instructions. Cells were assayed 96 h after
transfection.
Peptide pulldowns. Tissues were homogenized in a Dounce homogenizer in 5
volumes of buffer HNMD (HEPES-KOH, 50 mM [pH 7.4]; NaCl, 150 mM;
MgCl2, 1 mM; dithiothreitol [DTT], 1 mM; and freshly added protease inhibitors
and 1% Triton X-100). The homogenates were then centrifuged for 15 min at
27,000  g. The supernatants (10 mg/experiment at 1 mg/ml) were then pre-
cleared for 1 h at 4°C using streptavidin-Sepharose beads (100 l) (GE). At the
same time, 40 g of peptide was incubated with 40 l of streptavidin beads in
HNMD for 1 h at 4°C. The beads were then washed three times with HNMD and
incubated with 10 mg of precleared lysate for 1 h at 4°C on a rotating platform.
The beads were then washed three times in binding buffer, resuspended in 30 l
of sodium dodecyl sulfate (SDS) sample buffer, boiled for 10 min, and separated
by SDS-polyacrylamide gel electrophoresis (PAGE). The bands of interest were
then identified by matrix-assisted laser desorption ionization–time of flight mass
spectrometry (MS), and selected tryptic peptides were sequenced by Nano-ESI
tandem MS at the UNC proteomics facility.
GST pulldowns and immunoprecipitation. Cells were washed twice in phos-
phate-buffered saline (PBS), lysed in lysis buffer (HEPES-KOH, 50 mM [pH 7.4];
NaCl, 150 mM; MgCl2, 1 mM; DTT, 1 mM; and freshly added protease inhibitors
and 1% Triton X-100) and centrifuged at 16,000  g for 15 min at 4°C. Tissue
lysates were prepared as described above. Glutathione S-transferase (GST)-
tagged proteins bound to glutathione-Sepharose (GE) were incubated with ly-
sates for 1 h at 4°C. The beads were then washed three times in lysis buffer,
resuspended in 30 l of SDS sample buffer, boiled for 10 min, and separated by
SDS-PAGE. Proteins were then transferred to nitrocellulose and immunoblotted
with the indicated antibodies. For immunoprecipitation, cell lysates were incu-
bated with antibodies (2 g) and incubated for 1 h at 4°C. Protein G-Sepharose
(GE) was then added and incubated for 45 min at 4°C. Immune complexes were
recovered by centrifugation, washed three times with lysis buffer, and boiled in
SDS sample buffer. After SDS-PAGE, proteins were transferred to nitrocellulose
and immunoblotted with the indicated antibodies.
RhoA activity pulldowns. Construction of the pGEX4T-1 prokaryotic expres-
sion constructs containing the Rho binding domain (RBD) of rhotekin have been
described previously (36). Briefly, expression of the fusion proteins in Escherichia
coli was induced with 100 M IPTG (isopropyl--D-thiogalactopyranoside) for
12 to 16 h at room temperature. Bacterial cells were lysed in buffer containing 50
mM Tris (pH 7.6), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 10 g/ml each of
aprotinin and leupeptin, and 1 mM phenylmethylsulfonyl fluoride (PMSF) and
the proteins purified by incubation with glutathione-Sepharose 4B beads (GE) at
4°C. Active RhoA pulldown experiments were performed as described elsewhere
(3). Briefly, suspended and adherent cells were lysed in 50 mM Tris (pH 7.6), 500
mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate, 10 mM MgCl2, 200
M orthovanadate, and protease inhibitors. Lysates were clarified by centrifu-
gation, equalized for total volume and protein concentration, and rotated for 30
min with 30 g of purified GST-RBD bound to glutathione-Sepharose beads.
The bead pellets were washed in 50 mM Tris (pH 7.6), 150 mM NaCl, 1% Triton
X-100, 10 mM MgCl2, 200 M orthovanadate, and protease inhibitors and
subsequently processed for SDS-PAGE.
Subcellular fractionation. Intact nuclei were isolated using an iodixanol
(OptiPrep; Axis Shield) discontinuous gradient according to the manufacturer’s
instructions. Briefly, cells were rinsed three times with PBS and scraped in
homogenization medium (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM
Tris-HCl, pH 7.8, 10 g/ml each of aprotinin and leupeptin, and 1 mM PMSF).
Cells were then centrifuged for 10 min at 1,000  g, and the pellet was resus-
pended in homogenization medium. The cell suspension was homogenized using
20 strokes of the pestle of a tight-fitting Dounce homogenizer. Homogenization
was monitored under a phase-contrast microscope until 	90% of the cells were
broken. The homogenate was then centrifuged to produce a crude nuclear pellet
(1,000  g for 10 min) and resuspended in homogenization medium. Equal
volumes of the crude nuclear pellet and a 50% iodixanol solution were then
mixed and layered on top of a 30% to 35% discontinuous iodixanol gradient. The
samples were then centrifuged at 10,000  g for 20 min in a swinging bucket
rotor. The nuclear fraction (30 to 35% interface) was collected, diluted with 2
volumes of homogenization medium, and centrifuged for 10 min at 1,000  g.
The pellet fraction, which contains nuclei, was resuspended in 100 l of ice-cold
nuclear extraction buffer (20 mM HEPES, pH 7.9, with 1.5 mM MgCl2, 0.42 M
NaCl, 0.2 mM EDTA, 25% [vol/vol] glycerol, 10 g/ml each of aprotinin and
leupeptin, and 1 mM PMSF) and vortexed at the highest setting for 15 seconds
every 10 min for a total of 40 min of extraction. The samples were then briefly
sonicated and centrifuged at maximum speed (
16,000  g) in a microcentrifuge
for 10 min, and the supernatant (nuclear extract) fraction was transferred to a
clean, prechilled tube. Samples were stored at 80°C until use.
Immunofluorescence microscopy. Cells grown on coverslips were washed in
PBS, fixed in 3.7% paraformaldehyde for 10 min, and quenched with 10 mM
ammonium chloride in PBS. Cells were permeabilized with 0.1% Triton X-100
in PBS for 10 min. The coverslips were then washed with PBS and blocked in
PBS plus 2.5% goat serum and 0.2% Tween 20 for 5 min, followed by blocking
in PBS plus 0.4% fish skin gelatin and 0.2% Tween 20. Cells were incubated with
primary antibody for 1 h at room temperature. Coverslips were washed five times
for 5 min with PBS plus 0.2% Tween 20 and incubated with secondary antibodies
for 45 min. Coverslips were washed as described above and mounted on slides in
9:1 glycerol-PBS with 0.1% p-phenylenediamine. Epifluorescence images were
captured with a Zeiss Axiovert 200 M microscope equipped with a Hamamatsu
ORCA-ERAG digital camera and Metamorph Workstation (Universal Imaging
Corp.). Quantitative analysis was performed using Metamorph to measure the
average fluorescence intensity per cell in images that were serially acquired using
the same illumination and exposure parameters. Confocal image acquisition and
analysis were performed using a Leica SP2 AOBS confocal microscope with a
63, 1.4-numerical-aperture apochromatic Leica lens (Leica Microsystems).
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Scanning was performed with the xy axis, using three independent laser sources
(364-nm-UV, 488-nm-Ar, 568-nm-Kr lasers), as required. Images were processed
using Leica and Adobe Photoshop software.
Focus formation assays. Primary focus formation assays were performed with
NIH 3T3 cells as described previously (58). Briefly, NIH 3T3 cells were trans-
fected using the Amaxa nucleofection system (6 to 8 g of DNA/1  106 to 2 
106 cells) and plated into three 6-cm-diameter dishes. Twenty-four hours after
transfection, the bovine calf serum concentration was reduced from 10% to 5%.
Medium was changed every 2.5 days. Cells were fixed 12 to 14 days later and
stained with a solution containing 30% methanol and 0.4% crystal violet. Foci
larger than 1 mm in diameter were scored.
Electron microscopy. HeLa cells were plated on coverslips and grown for 24 h.
Cells were then transfected and chemically fixed in 2.5% glutaraldehyde and 1%
tannic acid in 0.1 M cacodylate buffer (pH 7.3) for 1 h at 4°C. Following fixation,
cells were washed with 0.1 M cacodylate buffer, treated for 1 h with cold 0.5%
osmium tetroxide, washed with water and once with 50% ethanol, stained with
2% uranyl acetate in the dark for 30 min, and dehydrated through a graded
ethanol series. Sections were infiltrated and embedded in an epoxy resin
(EMbed-812; Electron Microscopy Sciences). Vibratome sections were bisected
along the equatorial and optic axes and mounted for ultramicrotome sectioning.
Mesas were raised in the regions of interest, and 55-nm thin sections were cut
with a diamond knife (Diatome). The sections were collected on copper grids
and stained with uranyl acetate and lead citrate. The specimens were examined
using an FEI Philips Tecnai 12 TEM electron microscope (FEI Company) at 80
kV. Images were captured using a Gatan 794 digital camera (Gatan Inc.) and
Digital Micrograph software (Gatan Inc.).
RESULTS
Interaction between Net1 and PDZ-containing proteins. We
used a peptide pulldown approach coupled with MS analysis to
determine if the PDZ-binding motif present at the C terminus
of Net1 was able to bind PDZ domain-containing proteins. We
synthesized an NH3-biotinylated peptide corresponding to the
last 10 amino acids of human Net1 as well as a control peptide
in which the last 4 amino acids were replaced by glycine (Fig.
1B). We then used these peptides to isolate binding proteins
from different mouse tissues, including brain, liver, and kidney.
The proteins were separated in an SDS-PAGE gel and stained
with Coomassie blue dye. The bands of interest were cut from
the gel and identified by MS. Shown in Fig. 1C are the results
of two representative pulldowns from brain and liver. Although
there were some bands that appeared in both the peptide and
the control lane, several other bands were found exclusively in
the peptide lane. As shown in Fig. 1C, we were able to identify
most of the peptide-specific bands by MS. Almost all of the
proteins identified, with the exception of Hsc70, correspond to
PDZ domain-containing proteins, including PSD95/SAP90/Dlg4,
SAP102/Dlg3, MAGI-1, and Dlgh2/MAGUK-p55 in brain; Dlg1/
SAP97, Pals2, and mCASK-B in liver; and Veli3/Lin7C in both
brain and liver as well as in kidney. The identities of a selected
set of the interacting proteins were confirmed by Western blot
analysis using commercially available antibodies. Figure 1D
shows that when peptide pulldowns similar to the ones used for
MS analysis were transferred to nitrocellulose and immuno-
blotted with Dlg1, SAP102, PSD95, and Lin7C antibodies, the
expected proteins were exclusively detected in the Net1 pep-
tide lane but not in the control lane. In addition, we used
full-length Net1 fused to GST to determine whether the full-
length protein also coprecipitated with the same proteins that
we observed in the peptide pulldowns. As a control, we used a
similar GST fusion protein, in which the last four amino acids,
carrying the PDZ-binding motif, had been deleted (Net14-
GST) or a single-amino-acid-substitution mutant in which the
C-terminal amino acid valine was replaced by an alanine
(Net1V3A-GST). In agreement with the results from the pep-
tide pulldowns, only the full-length Net1 protein was able to
interact with PSD95, Dlg1, and SAP102, not the 4 mutant or
the V3A mutant, suggesting that these interactions were spe-
cifically mediated by the PDZ-binding motif at the C terminus
of Net1 (Fig. 1E and F). This interaction is direct and requires
PDZ domains 1 and 2 from Dlg1 (H. S. Carr and J. A. Frost,
personal communication). To confirm that the interaction also
occurred with endogenous proteins, we immunoprecipitated
Dlg1 from HEK293 lysates and blotted for Net1. As shown in
Fig. 1G, Net1 coimmunoprecipitated with Dlg1 antibodies but
not with control antibodies. In addition, we were able to co-
immunoprecipitate endogenous Dlg1 and Net1 from purified
nuclei (see Fig. S3B in the supplemental material). The reverse
coimmunoprecipitation could not be performed successfully,
because the Net1 antibodies available were raised against a
peptide corresponding to the Net1 C terminus, which includes
the PDZ-binding tail, a region that is probably masked when
the two proteins interact.
Interaction with Net1 causes the relocalization of Dlg pro-
teins from the cytosol to defined nuclear subdomains. In many
cases, the interaction of a protein with a PDZ domain-contain-
ing protein plays a role in targeting the protein to a specific
cellular localization. In particular, PDZ scaffolding proteins
such as PSD95, Dlg1, and SAP102 have been shown to con-
centrate or cluster neurotransmitter receptors at the plasma
membrane in the postsynaptic dendritic spines (13, 27, 56).
This same effect was observed when the two interaction part-
ners were transfected in a heterologous cell system (31, 32).
Since Net1 shuttles between the nucleus and the cytosol, we
hypothesized that its interaction with a PDZ protein in the
cytosol may play a role in targeting and/or sequestering Net1 in
the cytosol, where it can activate RhoA and perform its cellular
function. To test this hypothesis, we cotransfected full-length,
myc epitope-tagged Net1 with PSD95, SAP102, or Dlg1 into
HeLa cells. Each PDZ protein was fused to GFP to allow for
visualization of its localization. Our results show that, as pre-
viously reported, Net1 localized to the nucleus and to some
extent to the cytosol when singly transfected (Fig. 2A) (1, 49,
55).
Interestingly, cotransfection of Net1 with PSD95, Dlg1, or
SAP102 induced a striking redistribution of these PDZ pro-
teins from a diffuse cytosolic staining (Fig. 2C) to a series of
spatially restricted subdomains inside the nucleus (Fig. 2B). In
any given experiment, approximately 60% of the cotransfected
cells presented these nuclear clusters. The nuclear structures
differed in shape, size, and number, ranging from 2 to 83
clusters per cell (average  26.4 clusters/cell), with a typical
size ranging between 0.1 and 1 m2. With epifluorescence, the
signal for Net1 in the nucleus was too bright to determine if
Net1 colocalized with the PDZ proteins in these nuclear clus-
ters. However, analysis using confocal microscopy showed a
high degree of colocalization between Net1 and its interaction
partners (Fig. 2D). Identical results were observed in COS-7,
HEK293, and NIH-3T3 cells, indicating that this was a general
effect and not a cell line-specific result (data not shown). At the
ultrastructural level, cotransfected cells contained a collection
of electron-dense particles distributed throughout the nucleus,
ranging from 0.1 m to 2 m in diameter, that were not
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FIG. 2. HeLa cells were cotransfected with myc-Net1A and either PSD95-GFP, Dlg1-GFP, SAP102-GFP, or GFP alone; processed for
immunofluorescence using anti-myc antibodies (red); and analyzed also for the GFP signal (green). Actin was stained with Alexa 594-phalloidin.
Nuclear DNA was stained with Hoechst (blue). (A) Net1A localizes to the nucleus and to some extent to the cytosol when transfected alone.
(B) Cotransfection of Net1A with any of the Dlg proteins induces a striking redistribution from a diffuse cytosolic staining (C) to a series of
restricted subdomains within the nucleus. (C) The three Dlg proteins show a diffuse distribution in the cytosol in singly transfected cells.
(D) Confocal sections show that both Net1 and SAP102 colocalize within the nuclear subdomains. (E) Ultrastructural analysis shows electron-
dense particles in cells cotransfected with Net1A and PSD95-GFP or SAP102-GFP (arrowheads) that are not present in control cells and also
severely distorted nuclei. (F) Identical subnuclear structures were formed when Net1 was cotransfected with SAP102. (G, H) The formation of the
nuclear subdomains was not induced by coexpression of PSD95-GFP and XPLN, a protein homologous to Net1. Bar  10 m in all panels except
panel E (bar  2 m).
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present in control cells cotransfected with Net1 and an empty
GFP vector (Fig. 2E). Our initial experiments were carried out
using a splice variant of Net1, Net1A. However, identical re-
sults were observed with the longer isoform, Net1, in all the
experiments that we performed (Fig. 2F and 3E for quantifi-
cation; also data not shown). In the text, Net1 is used to
reference either Net1 or Net1A. However, each figure indi-
cates which particular isoform was used in each experiment. In
order to determine if this effect was specific to Net1, we per-
formed similar experiments using a related Rho GEF, XPLN/
ARHGEF3. XPLN is the closest Net1 homologue in the hu-
man genome (54% identity, 66% homology). It is RhoA
specific and induces the formation of actin stress fibers upon
overexpression (4) (Fig. 2G). XPLN also contains a PDZ-
binding motif at the C terminus and is able to coprecipitate
with PSD95 in peptide pulldowns (data not shown). However,
when PSD95 was coexpressed with XPLN, it did not redistrib-
ute to the nucleus, suggesting that the nuclear localization of
PSD95 was specific for Net1 (Fig. 2H and 3E for quantifica-
tion).
Deletion of the PDZ-binding motif in Net1 prevents the
relocalization of the PDZ proteins and the formation of nu-
clear clusters. To determine whether the effects that we ob-
served were specifically caused by the interaction between the
PDZ-binding motif of Net1 and the PDZ domain of each
protein, we eliminated the PDZ-binding site within Net1A by
introducing a stop codon (Net14). We have shown in Fig. 1
that the equivalent mutation in a NET-GST fusion protein
blocked binding to PSD95, Dlg1, and SAP102 in pulldown
experiments. We observed that the Net14 mutant behaved
like the full-length Net1 protein when transfected alone, local-
izing predominantly to the nucleus and causing the formation
of actin stress fibers when expressed at high levels (Fig. 3A).
Importantly, when Net14 was coexpressed with PSD95, Dlg1,
or SAP102, the relocalization of the PDZ proteins to the nu-
cleus and the formation of nuclear clusters were completely
abolished (Fig. 3B and E for quantification). Instead, each of
these proteins showed a diffuse, cytosolic pattern that was
indistinguishable from that observed when they were expressed
alone (Fig. 2B). These results demonstrate that Net1 must
interact with PDZ domain proteins through its PDZ-binding
site to cause their nuclear relocalization.
Formation of the nuclear clusters is independent of the
exchange activity of Net1. We next wanted to examine the role
of Net1 nucleotide exchange activity in the relocalization of the
PDZ proteins and the formation of the nuclear clusters. To
address this, we generated a single-amino-acid-substitution
mutant which has been previously shown to inhibit the catalytic
activity of Net1 (L321E in Net1, L267E in Net1A) (2). As
expected, overexpression of the inactive Net1 protein in HeLa
cells had no effect on stress fiber formation (Fig. 3C). Inter-
estingly, cotransfection of Net1-L267E with PSD95, Dlg1, or
SAP102 did not prevent the formation of nuclear clusters (Fig.
3D and F). Similarly, a mutation in the PH domain
(Net1W492L) previously described as catalytically inactive (2)
was as efficient as wild-type Net1 in its ability to recruit Dlg
proteins to the nucleus and target them to nuclear clusters
(data not shown). Taken together, these results demonstrate
that the relocalization of PDZ proteins into the nucleus and
the formation of nuclear clusters do not require Net1-medi-
ated RhoA activation.
The interaction between Net1 and Dlg proteins has no effect
in Net1-mediated RhoA activation. As shown in Fig. 3, the
formation of the nuclear clusters was not inhibited by abrogat-
ing the exchange activity in Net1. However, that did not elim-
inate the possibility that the interaction between Dlg proteins
and Net1 had an effect on Net1 exchange activity on RhoA. To
determine if this was the case, we transfected HeLa cells with
Net1N alone or in combination with two members of the Dlg
family, Dlg1 and SAP102. We then analyzed their effect on
RhoA activity by looking at the formation of stress fibers in
transfected cells. As shown in Fig. 4, overexpression of Net1N
induces a striking increase in the formation of stress fibers. In
contrast, neither Dlg1 nor SAP102 by itself had any effect on
stress fiber formation. When Dlg1 or SAP102 was cotrans-
fected with Net1N, we could not detect any significant dif-
ference from cells singly transfected with Net1N, suggesting
that the interaction was not affecting Net1 exchange activity.
Quantitation of F-actin fluorescence intensity supports our
conclusion and shows that there is no significant difference
between cells transfected with Net1N and those cotrans-
fected with Dlg protein (Fig. 4C). We also measured RhoA
GTP levels in a similar set of transfected cells by using a
pulldown assay. The results of the pulldown assay show essen-
tially the same results as those observed in the immunofluo-
rescence analysis, that is, Net1N induces RhoA activation
compared to what occurs in nontransfected, starved cells. This
activity is not affected significantly by cotransfecting Dlg1 or
SAP102 (Fig. 4D). Taken together, our results suggest that the
interaction between Net1 and Dlg proteins does not seem to be
involved in the regulation of Net1’s exchange activity.
Characterization of the nuclear clusters. There were a num-
ber of possible explanations for the formation of the nuclear
clusters that we observed. For example, a number of different
nuclear subdomains that resemble the Net1-PDZ protein clus-
ters have been characterized, including PML bodies, nuclear
speckles, and Cajal bodies (26, 59). However, it was also pos-
sible that the nuclear clusters were artifactual. For example,
proteins that tend to form aggregates such as polyglutamine
repeat-containing proteins have been shown to form nuclear
aggregates of similar size and shape (9, 57, 61, 72). Similarly,
overexpression of GFP chimeras has also been associated with
misfolding and aggregation (15, 17, 35). To rule out the pos-
sibility that the addition of GFP to the PDZ domain proteins
resulted in the nuclear clusters that we observed, we replaced
the GFP tag in some of the proteins with a smaller FLAG tag
and coexpressed it with Net1. As shown in Fig. 5A, the FLAG-
tagged Dlg1 and SAP102 proteins, upon coexpression with
Net1, translocated to nuclear subdomains that were indistin-
guishable from those formed by the GFP-tagged constructs. To
determine whether the Net1-induced nuclear clusters corre-
sponded to identifiable nuclear structures, we stained cells
cotransfected with Net1 and PSD95, Dlg1, or SAP102 with
known markers for nuclear subdomains. These markers in-
cluded PML protein for PML bodies, SC35 for nuclear speck-
les, and coilin for Cajal bodies. Figure 5B shows that of all
markers tested, only PML bodies colocalized with the clusters
induced by Net1 (shown for SAP102). In general, PML bodies
were located adjacent to or showed partial colocalization with
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FIG. 3. HeLa cells were cotransfected with a Net1A mutant in which the last four amino acids, corresponding to the PDZ-binding motif, have been
deleted (Net14) and either PSD95-GFP, Dlg1-GFP, SAP102-GFP, or GFP as a control and processed for immunofluorescence using anti-myc
antibodies (red). Cells were also analyzed for the GFP signal (green). (A) Net14 localizes to the nucleus and induces actin stress fibers in a manner
indistinguishable from that of wild-type Net1. (B) When Net14 is coexpressed with PSD95, Dlg1, or SAP102, the relocalization of these proteins to the
nucleus and the formation of nuclear clusters are completely abolished. The three Dlg proteins also show a diffuse localization that is identical to that
observed when they are expressed alone. (C) Catalytically inactive Net1 (L267E) fails to induce stress fibers when overexpressed in HeLa cells. (D) When
the catalytically inactive Net1 protein is cotransfected with either PSD95, Dlg1, or SAP102, the formation of nuclear subdomains is not affected,
suggesting that it is not dependent on the nucleotide exchange activity of Net1. (E, F) Experiments for Fig. 2B, 2H, 3B and 3D were quantified. At least
200 cells were counted for each condition and scored for the presence or absence of nuclear subdomains. Bar  10 m in all panels.
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the structures containing Net1 and PDZ proteins. We ob-
served a better colocalization with PML bodies in nuclear
clusters that were bigger, suggesting that smaller clusters may
coalesce and form bigger structures that could eventually as-
sociate with the PML bodies, as has been shown for other
proteins (15, 44). In contrast, SC35, the marker for nuclear
speckles, showed a pattern that was mutually exclusive with
that of the GFP-Dlg clusters, suggesting that the Net1-induced
nuclear domains were not speckles (Fig. 5B). Cajal bodies
colocalized to some extent with the GFP-Dlg clusters (Fig. 5B).
FIG. 4. HeLa cells were transfected with mycNet1N, Dlg1-GFP, or SAP102-GFP alone or in combination as indicated in the figure and
processed for immunofluorescence by using monoclonal anti-myc antibodies (blue) and Alexa 594-phalloidin (red). Cells were also analyzed for
the GFP signal (green). (A, B) Overexpression of Net1N (the arrowhead indicates a representative cell) but not Dlg1-GFP or SAP102-GFP
(arrow) induces the formation of stress fibers. Coexpression of Dlg1-GFP or SAP102-GFP with Net1N does not affect Net1-mediated stress fiber
formation (the arrowhead indicates a representative cell transfected with either Dlg1-GFP or SAP102-GFP with Net1N). (A) A representative
panel for each transfection is shown. The constructs used for each condition are indicated on top of each panel. (B) Alexa 594-phalloidin-stained
images used for quantification. A representative image is shown. Arrowheads indicate cells transfected with the constructs indicated in panel A.
(C) To quantify stress fiber formation, the average fluorescence intensity per cell in the red channel was measured. The fluorescence intensities
in the green and blue channels were also measured to identify transfected cells. All images were acquired using the same exposure parameters.
At least 25 cells were counted for each condition. Significance of difference from the control (et1) was estimated by Student’s t test for
nonpaired values. Bars not significantly different from the control values were left unmarked. An asterisk signifies a P value of 0.001. Bar  10
m in all panels. (D) HEK293 cells were transfected with mycNet1N, Dlg1-GFP, or SAP102-GFP alone or in combination as indicated in the
figure. Active Rho was specifically pulled down from cell lysates containing equal amounts of proteins with immobilized recombinant RBD-GST
and analyzed by Western blotting using anti-RhoA antibody. Results for a representative experiment are shown.
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However, there were never more than six Cajal bodies per cell
and we observed up to 80 Dlg clusters in a single cell, suggest-
ing that most Net1-PDZ protein clusters were not Cajal bodies.
However, it has been shown that one of the Cajal bodies is
always associated with PML bodies, suggesting that the limited
colocalization observed may not be coincidental (21).
Deletion of the NLS in Net1 prevents nuclear cluster for-
mation. There are two alternatively spliced variants of Net1:
Net1 and Net1A. Net1A is identical to Net1 except for its
amino terminus, which is approximately 60 amino acids shorter
(Fig. 6A). It has been previously shown that the information
required to target both Net1 isoforms to the nucleus is en-
coded at their N termini and that mutations in this region
result in the redistribution of both proteins to the cytosol (42,
49, 55). There are at least four patches of basic amino acids at
the N terminus of Net1 that have been recognized as important
for targeting it to the nucleus (Fig. 6A) (42, 49, 55). We have
observed that both Net1 and Net1A were indistinguishable in
their ability to translocate Dlg proteins to the nucleus (Fig. 2).
Net1 lacking its N terminus (oncoNet1) (Fig. 6A) has been
shown to be transforming in NIH 3T3 cells (2, 8, 49). To
determine whether oncoNet1 interacted with its PDZ-binding
partners in a manner analogous to that of its wild-type coun-
terparts, we generated a similar deletion mutant () (Fig.
6A) and coexpressed it with PSD95, Dlg1, or SAP102 in HeLa
cells. As previously described, while the  mutant was still
able to target to the nucleus to a small extent, the majority of
the protein localized to the cytosol (Fig. 6B) (49, 55). Surpris-
ingly, when Net1 was coexpressed with the PDZ proteins,
the PDZ protein clusters are still formed, but they were com-
pletely excluded from the nucleus and instead distributed
evenly throughout the cytosol (Fig. 6C). The cytosolic clusters
did not appear to contain Net1, as judged by the myc
staining. However, when we repeated the experiment using an
mCherry-labeled Net1 mutant, we observed perfect colo-
calization, suggesting that the inability to see Net1 in the
cytosolic clusters was attributable to a lack of accessibility of
the myc epitope (see Fig. S1 in the supplemental material). We
also observed that the formation of these cytosolic clusters was
abrogated by deleting the PDZ-binding site in Net1, indi-
cating the requirement for interaction between Net1 and PDZ-
binding proteins for cluster formation (shown for SAP102 co-
transfection in Fig. 6D). These data also indicate that nuclear
localization is not a requisite for these coclusters to form.
Endogenous Dlg1 localization is affected by overexpression
of Net1 or by reduction of endogenous Net1 levels. We also
wanted to determine if overexpression of Net1 or Net1 mu-
tants was able to affect the localization of endogenous Dlg1.
We therefore transfected MCF10a cells, which express endog-
enous Dlg1, with different Net1 constructs and analyzed Dlg1
localization by immunofluorescence. Figure 7A shows that
overexpression of full-length Net1 promoted the translocation
of Dlg1 from cell junctions to the nucleus. In many cases, we
found Dlg1 colocalizing with Net1 in nuclear subdomains sim-
ilar to those observed in the cotransfection experiments. The
relocation of Dlg1 was completely abolished when we overex-
pressed Net14, which is still targeted to the nucleus but is
unable to bind Dlg1, suggesting that it is being mediated by the
FIG. 5. (A) HeLa cells were cotransfected with myc-Net1A and either FLAG-Dlg1 or FLAG-SAP102 and processed for immunofluorescence
using anti-FLAG (green) and anti-myc (red) antibodies. FLAG-tagged Dlg1 and SAP102 form nuclear subdomains that are identical to those
formed by the GFP-tagged proteins, suggesting that GFP is not promoting the formation of these structures. (B) HeLa cells were cotransfected
with myc-Net1A and either PSD95-GFP, Dlg1-GFP, or SAP102-GFP and processed for immunofluorescence using anti-PML (PML bodies),
anti-SC35 (speckles), and anticoilin (Cajal bodies) antibodies (red) and analyzed also for the GFP signal (green). PML bodies showed partial
colocalization with the clusters induced by Net1 (arrowheads). The arrow indicates a Cajal body colocalizing with a Net1 cluster. Bar  10 m in
all panels.
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interaction between the PDZ domains in Dlg1 and the PDZ-
binding tail in Net1 (Fig. 7B). XPLN, another RhoA GEF that
also binds PDZ proteins, is unable to relocate Dlg1 upon
overexpression, suggesting that the effect observed is specific
for Net1 (Fig. 7C). In addition, Net1N, which is mostly cyto-
solic, also promotes the relocation of endogenous Dlg1, this
time from cell junctions to a diffuse cytosolic pattern. In some
cells, we observed cytosolic clusters similar to the ones shown
in Fig. 6 (Fig. 7D). It appears in some of the images in Fig. 7
that only the transfected cells are expressing Dlg1. There are
two main reasons for this apparent anomaly. First, methanol
fixation, which is required to visualize nuclear Dlg1, signifi-
cantly decreases the Dlg1 signal at the membranes. Second, the
signal of nuclear Dlg1 in transfected cells is highly concen-
trated in a small area, making it difficult for the camera to
capture the weaker signal at the junctions. Overall, it appears
that the junctional staining is reduced and nuclear staining (or
cytosolic staining in the case of N) is greatly increased in
transfected cells, while in reality, Dlg1 relocates only upon
transfection and the difference observed is caused by the re-
duction in junctional staining resulting from the methanol fix-
ation (see Fig. S2 in the supplemental material). We also
tested the stability of Dlg1 upon Net1 transfection to see if
Net1 overexpression could confer stability to Dlg1 and cause
its accumulation over time. We transfected cells with different
amounts of Net1 or Net1N and then blotted for Dlg1 to see
if we could detect an increase in Dlg1 levels in transfected cells.
Our results showed that Net1 or Net1N failed to increase
Dlg1 stability and, under at least one condition, even caused a
slight decrease in Dlg1 levels. These results suggest that the
stability of Dlg1 is not responsible for the apparent accumula-
tion observed in transfected cells (see Fig. S2C and E in the
supplemental material).
To determine if endogenous Net1 was playing a role in
targeting Dlg1 to the nucleus, we first decided to address
whether we were able to detect endogenous Dlg1 in nuclear
fractions. Detection of nuclear Dlg1 by immunofluorescence
has already been reported (39, 40). We were also able to detect
Dlg1 in the nucleus in certain cell lines, including MCF7,
especially when they are not polarized (Fig. 7E). In addition,
we analyzed for the presence of endogenous Dlg1 in the nu-
cleus by using subcellular fractionation. We optimized a pro-
FIG. 6. (A) N-terminal domains of Net1 and Net1A. The oncogenic mutants and deletion mutants used in this study are indicated. NLS are shaded
in orange and were previously characterized in references 55 (regions 1 and 2), 42 (regions 3 and 4), and 49 (region 5). (B) Overexpression of mycNet1.
Net1 localizes to the nucleus and to the cytosol. (C) Single and double transfections were performed with HeLa cells, combining mycNet1 with
either GFP-PSD95, GFP-Dlg1, or GFP-SAP102. The cells were then fixed and processed for immunofluorescence using anti-myc antibodies (red) and
analyzed also for the GFP signal (green). Deletion of the NLS in Net1 inhibits the formation of nuclear subdomains. The two proteins are still able to
cocluster in the cytosol. (D) Deletion of the PDZ-binding motif in Net1 (Net14) abolishes the relocalization and clustering of the Dlg proteins
in the cytosol (shown for SAP102). Bar  10 m in all panels.
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FIG. 7. MCF10a cells were transfected with the indicated constructs and processed for immunofluorescence, using anti-myc antibodies (red)
to detect transfected cells, and analyzed also for endogenous Dlg1 by using anti-Dlg1 antibodies (green). Nuclear DNA was stained with Hoechst
(blue). (A) Expression of Net1 promotes the redistribution of endogenous Dlg1 from the cell junctions to the nucleus (two representative cells are
shown). (B) Deletion of the last four amino acids in Net1 (Net14) inhibits Dlg1 recruitment to the nucleus. (C) Expression of Net1’s closest
homologue, XPLN, has no effect in the localization of endogenous Dlg1. (D) Expression of the oncogenic Net1 protein (Net1) promotes the
redistribution of endogenous Dlg1 from cell junctions to a diffuse cytosolic localization. Arrowheads indicate cytosolic clusters containing Dlg1 and
Net1N. (E) MCF7 cells were plated on coverslips and processed for immunofluorescence using anti-Dlg1 antibodies. The arrowhead indicates
nuclear Dlg1. (F) Schematics of the discontinuous gradient utilized to isolate nuclei. Nucleus sediment in the 30 to 35% iodixanol interface is
shown. The majority of the soluble proteins are recovered in the top fraction. (G) Representative image of a nuclear fraction. Nuclei were mixed
1:1 in mounting solution containing Hoechst to stain DNA. (H) Characterization of isolated nuclei. Proteins were separated by SDS-PAGE and
immunoblotted for Dlg1, Net1, tubulin, lamin, and actin. (I) HEK293 cells were transfected with siRNA specific for Net1 or a nontargeting control
siRNA. Ninety-six hours after transfection, nuclei were isolated as described in Materials and Methods. Equal amounts of protein from each
fraction were then separated by SDS-PAGE and immunoblotted for Dlg1 and Net1. Membranes were stripped and reblotted for tubulin and lamin
as loading controls for the top and nuclear fractions, respectively. Nuclear Dlg1 decreases when Net1 levels are reduced by siRNA treatment.
(J) The amount of Dlg1 in each fraction was quantified by densitometric analysis. Values were normalized in relation to the control (ctrl) condition
for each fraction. The results from three independent experiments were analyzed. Error bars represent standard errors of the means. Significance
of difference from the control was estimated by Student’s t test for paired values. Values that are significantly different from the control are marked
with an asterisk. P  0.0348 for the top fraction; P  0.0033 for the nuclear fraction. Bar  10 m in all panels.
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tocol that uses a discontinuous gradient of iodixanol (Opti-
Prep) and allows for the purification of intact nuclei in a
relatively simple approach. A schematic of the gradient utilized
and the fractions analyzed is depicted in Fig. 7F, and a repre-
sentative microscopic image of a typical nuclear fraction is
shown in Fig. 7G. Western blot analysis of the gradient frac-
tions shows that the nuclear envelope protein lamin is found
exclusively in the nuclear fraction, while soluble proteins like
tubulin and actin are almost exclusively found in the soluble
(top) fraction (Fig. 7H). Endogenous Net1, as expected, was
highly enriched in the nuclear fractions. Interestingly, while the
majority of Dlg1 can be found in the soluble (top) fraction, a
significant amount of Dlg1 was consistently found in the nu-
clear fractions. We estimated the amount of Dlg1 in the nu-
clear fraction to be approximately 2 to 4% of the total Dlg1
protein. We then wanted to determine if the localization of
Dlg1 in the nucleus was mediated by Net1. If Net1 is involved
in targeting Dlg1 to the nucleus, then specific knockdown of
Net1 should release Dlg1 from the nucleus. To address this
question, we transfected cells with a Net1-specific siRNA
oligonucleotide or with a control nontargeting siRNA and then
prepared nuclei as described above and analyzed them for the
presence of Dlg1 in the different fractions. As shown in Fig. 7I,
Net1 levels were efficiently reduced by the siRNA oligonucle-
otide but not under the control condition. Following fraction-
ation, we observed a redistribution of Dlg1 levels between the
nuclear and the soluble fractions. The reduction of Net1 levels
caused a statistically significant reduction in the levels of nu-
clear Dlg1 and a concomitant increase in the soluble Dlg1
levels (Fig. 7I and J), suggesting that nuclear Dlg1 is being
released to the cytosol upon Net1 depletion. The fact that Dlg1
reduction was not complete can be attributed in part to resid-
ual levels of Net1 in the nucleus. Alternatively, other PDZ-
binding proteins or binding partners may be contributing to the
shuttling or retention of some Dlg1 in the nucleus. In sum-
mary, our results suggest that endogenous Dlg1 is found in the
nucleus and that Net1 plays a role in its nuclear localization.
Role of Net1 interaction with PDZ proteins in transforma-
tion. The observation that coexpression of the oncogenic
Net1N mutant with PDZ domain proteins caused the forma-
tion of clusters in the cytosol suggests that Net1N may se-
quester these proteins from their natural partners/effectors and
prevent them from performing their normal function. Interest-
ingly, Dlg1/SAP97 has been shown to function as a tumor
suppressor protein in Drosophila and in mammals (20, 45, 64,
69–71). In addition, a mutant of Net1N lacking its PDZ-
binding motif loses its transformation potential, suggesting
that binding to a PDZ protein is required for transformation
(49). We hypothesized that the transformation ability of
Net1N was dependent on its ability to bind and sequester
Dlg1 (or other Dlg proteins) in the cytosol, away from its
normal cellular location and/or binding partners. One predic-
tion of this hypothesis is that if we restore the amount of Dlg1
by overexpressing it, there would be enough “active” or “free”
Dlg1 that can act as a tumor suppressor and reduce Net1N
transformation potential. To test this prediction, we coex-
pressed wild-type and oncogenic Net1, alone or together with
Dlg1 or SAP102, in NIH 3T3 cells and performed a focus
formation assay. As previously described, wild-type Net1 was
unable to induce transformation while expression of Net1N
induced a significant increase in the number of foci formed
after 2 weeks (Fig. 8A and B) (2, 49). However, when either
Dlg1 or SAP102 was coexpressed with Net1N, a significant
reduction in the number of colonies was observed. To rule out
that the observed reduction was simply a result of overexpress-
ing a tumor suppressor, SAP102 was coexpressed with another
RhoA GEF, p115-RhoGEF, which upon deletion of its C ter-
minus is also a potent oncogene (10, 16, 68). Oncogenic p115-
RhoGEF (p115C) does not contain a PDZ-binding site and
has not been shown to interact with SAP102 (18). Our results
FIG. 8. (A, C) Representative focus formation assay in NIH 3T3 cells. NIH 3T3 cells were transfected with the indicated constructs and
analyzed for the formation of foci. (B, D) The data shown are representative of two independent experiments performed in triplicate and represent
average numbers of foci generated. Error bars represent standard deviations. Significance of difference from the control ( in panel B, p115C
in panel D) was estimated by Student’s t test for nonpaired values. Bars not significantly different from the control values were left unmarked. An
asterisk signifies a P value of 0.001.
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show that coexpression of SAP102 with the oncogenic p115-
RhoGEF had no effect on the number of foci formed after 2
weeks, suggesting that its effect on Net1N-mediated transfor-
mation was specific (Fig. 8C and D).
DISCUSSION
There is now considerable evidence that aberrant function of
Rho GTPases plays a significant role in cancer development.
For example, constitutively active Rho mutants are capable of
transforming fibroblasts and dominant-negative mutants can
prevent Ras-mediated transformation (53). However, unlike
for Ras, there are no reports of mutated, constitutively active
forms of Rho proteins in tumors, suggesting that the mecha-
nisms involving Rho GTPase deregulation are indirect and
involve alterations in Rho GTPase expression and activation
(30, 53). In contrast to Rho GTPases, Rho GEFs do acquire
activating mutations, making these activators the best candi-
dates for aberrant Rho GTPase regulation in human cancer.
Many GEFs, including Dbl, Lbc, Lfc, Lsc, Dbs, Vav, Ect2, Tim,
and Net1, were originally isolated as truncated oncogenes by
using NIH 3T3 fibroblast transformation assays with DNA
derived from various human tumors (54). These Rho GEFs are
usually more potent oncogenes than their corresponding Rho
GTPase mutants, suggesting that the ability to cycle between
GTP- and GDP-bound states is important for Rho protein-
mediated transformation.
Originally, it was thought that the ability of Net1 to trans-
form cells was due to the fact that the N mutant was consti-
tutively active in the cytosol (55). However, it was later shown
that wild-type Net1 artificially targeted to the cytosol is still
active but cannot induce transformation (49). In addition, it
was also shown that deletion of the last four amino acids in
Net1, carrying a consensus PDZ-binding motif, abrogated its
transformation properties but not its exchange activity, sug-
gesting that binding to a PDZ protein was necessary for the
process of transformation (49).
In this study, we identified several PDZ domain-containing
proteins as potential binding partners for Net1 and specifically
characterized the interaction of Net1 with three members of
the Dlg family of proteins, PSD95, Dlg1/SAP97, and SAP102.
We found that the binding of Net1 to these proteins promotes
their relocation from the cytosol to discrete nuclear subdo-
mains. This relocation requires the PDZ-binding domain and
the NLS in Net1. In addition, we found that reducing Net1
levels using siRNA causes a redistribution of endogenous Dlg1
from the nucleus to the cytosol.
Although most PDZ proteins are associated with plasma
membrane-bound proteins, there are several examples in the
literature of PDZ proteins, including Dlg1, that are able to
shuttle between the nucleus and the cytosol. For example,
endogenous Dlg has been shown to localize to the nucleus in
various cell types and tissues (39, 40). In this regard, Dlg1 is
predicted to contain four or five putative NLS, but it is not
clear which ones contribute to the nuclear localization (40).
CASK, another member of the MAGUK family of proteins,
has also been found to shuttle between the nucleus and the
cytosol (29). CASK interacts with Tbr1, a transcription factor
involved in mouse forebrain development. Once in the nu-
cleus, CASK and Tbr-1 bind to a specific DNA sequence (the
T element). In this context, CASK acts as a coactivator of
Tbr-1 to induce the transcription of T-element-containing
genes (29). Similarly, a splice variant of the PDZ protein
NHERF2, named SIP-1, was identified as a nuclear factor
binding to SRY, a Y-chromosome-specific gene that acts as a
trigger for male sex development (48). SIP-1 is also proposed
to function as a transcriptional coactivator (48, 63). Taken
together, these studies suggest potential roles for some PDZ
proteins in the nucleus, most likely associated with transcrip-
tional regulation.
The interaction between Net1 and members of the Dlg fam-
ily not only targets them to the nucleus but also localizes the
complexes in discrete nuclear subdomains. The nucleus is or-
ganized into many functionally specialized subdomains that
have been characterized as organelles (26, 59). Subnuclear
organelles differ in size, shape, and molecular components, and
the functions of most of these organelles are still unknown.
Our work suggests that the structures formed by Net1 in com-
plex with PDZ proteins are closely associated with PML bod-
ies. PML bodies, also known as PML oncogenic domains or
nuclear domain 10 (ND10), are defined by the presence of the
PML protein. Approximately 10 to 30 bodies are observed in
each cell, ranging from 
0.2 to 1.0 m each. PML bodies are
multiprotein complexes that have been shown to contain at
least 50 different proteins (41). Studies of the physiological role
of PML bodies and the PML protein have shown that they play
a role in transformation suppression, growth control, differen-
tiation, and immune response pathways (6, 41). It would be
interesting to determine if the ability of Dlg1 to localize to the
nucleus in close association with PML bodies is correlated to
its tumor suppressor function.
Dlg1 is the mammalian homolog of the Drosophila discs-
large (Dlg) tumor suppressor protein (38, 43). Loss of zygotic
Dlg in Drosophila causes cellular outgrowth in larval brain and
imaginal discs (20, 70, 71). Transgenic expression of mamma-
lian Dlg1 and SAP102 can suppress tumor formation in dlg
mutant flies and mimic Dlg at larval neuromuscular junctions,
demonstrating a conservation in the tumor suppressor function
(64). Dlg1 has also been shown to prevent unscheduled growth
in mouse retina (45). Our data suggest that oncogenic Net1
may promote transformation by promoting the translocation of
Dlg1, PSD95, and SAP102 into cytosolic clusters. This may
sequester Dlg1 away from its normal localization or compete
for other binding partners to promote unrestricted growth and
transformation. In a similar manner, several viral oncoproteins
that contain PDZ-binding tails have been shown to interact
with Dlg1 and other PDZ-containing proteins (33, 34, 52). It
has also been shown that the PDZ-binding motif plays a role in
transformation induced by these oncoproteins (28, 34, 66).
Upon interacting with Dlg1, these viral proteins inactivate the
tumor suppressor protein through different molecular mecha-
nisms. For example, the high-risk human papillomavirus E6
protein targets human Dlg1 (hDlg) and PSD95 (Dlg4) for
degradation (19, 25). Significantly, only E6 proteins that are
derived from oncogenic human papillomavirus types can inter-
act with hDlg, and E6 mutants that can no longer bind hDlg
also lose their transforming activity (33). In addition, E6 has
been shown to colocalize at the nucleus with PML bodies (22,
23). Similarly, the viral oncoprotein Tax1, which is from human
T-cell leukemia virus 1, can also bind to Dlg1 and perturb its
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tumor suppression function, by a mechanism that does not
involve degradation of Dlg1 (60). In contrast, the adenovirus
type 9 E4-ORF1 oncoprotein induces transformation by bind-
ing to Dlg1 through a pathway that requires Src-dependent
phosphatidylinositol 3-kinase activation (14). In this regard, we
have not observed degradation of Dlg1 or the other PDZ
proteins upon interaction with Net1, but it is possible that the
cytosolic aggregation or clustering may also inhibit the tumor
suppressor function of Dlg1 by preventing it from interacting
with its physiological binding partners or from targeting to its
appropriate cellular destination. Future experiments will be
directed to characterize the molecular mechanisms by which
the interaction between Net1 and PDZ proteins contributes to
Net1-dependent transformation.
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